Many recent NACDS RxIMPACT pharmacy tours have been directly with members of Congress themselves—68 percent so far this year.
Members of Congress were able to grasp firsthand critical pharmacy public policy issues when they toured pharmacies in their home states and congressional districts.
During the Fourth of July congressional recess, members of Congress learned firsthand about key pharmacy issues—particularly about the need for direct and indirect remuneration (DIR) fee relief as part of a drug-pricing legislative package.
DIR Fee Relief is Focus of Largest-Ever NACDS RxIMPACT Push Effort underway to help advance Phair Pricing Act
DIR fee relief is motivating a record-breaking NACDS RxIMPACT Congressional letter-writing campaign. The effort to end the abuse of DIR fees includes three focuses right now. Learn more.